Page last updated: 2024-11-06

prednisolone and Acroosteolysis, Giaccai Type

prednisolone has been researched along with Acroosteolysis, Giaccai Type in 2 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anlar, B1
Deda, G1
Erdem, S1
Tan, E1
Korkusuz, P1
Miyazaki, M1

Other Studies

2 other studies available for prednisolone and Acroosteolysis, Giaccai Type

ArticleYear
Chronic acquired polyneuropathy in infancy.
    Journal of neurology, 2002, Volume: 249, Issue:10

    Topics: Age of Onset; Anti-Inflammatory Agents; Chronic Disease; Demyelinating Diseases; Diagnosis, Differen

2002
[Childhood-onset neuropathy associated with elevated serum antibody against GM 1-ganglioside].
    No to hattatsu = Brain and development, 1994, Volume: 26, Issue:6

    Topics: Adolescent; Age of Onset; Autoantibodies; Diagnosis, Differential; Female; G(M1) Ganglioside; Heredi

1994